The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Borrower

F•••• T••••••••• G••••• I••

Drug Discovery & Developmentgroup grade Aoff every schedule since Dec 31, 2022sponsor unattributed
See every lender's markFind rescue capital
More
Special situations PE firms

Nothing material in the last 200 days. Last change: 31 Dec 2022, $15M principal held by 1 lender; matures Nov 2026.

Principal held
at least $15.0M
sum of BDC pieces, a lower bound
Fair value
$13.9M
93c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
0 equity pieces beside them
Next maturity
Nov 1, 2026
no dated debt inside 24 months
On the tape since
Dec 31, 2022
latest Dec 31, 2022
Events
1
dated, non-routine
Lender marks
each lender's own fair value over cost at Dec 31, 2022, folded to one row per lender
LenderExposureCurrent markQoQ change
H••••••• C••••••• I•••$15M93¢new this quarter
Every BDC piece · 1 position across 1 lenderlargest principal first, with instrument and rate
BDCInstrumentPrincipalFair valueRate
H••••••• C••••••• I•••term loan first lien
S••••• S••••••, M••••••• D••• N••••••• 2026, P•••• + 4.05%, F•••• rate 7.55%, Cap rate 8.8
$15.0M$13.9M
93c
S+405 bp
Capital structure as the BDCs see it
latest quarter end Dec 31, 2022
FacilityHeldOn costPricingMaturityBDCs
first lien term loan first lien
exited Dec 31, 2022
at least $15.0M93cS+405 bpNov 1, 20261
Through time
the borrower's pieces summed across BDCs, every quarter end
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Dec 31, 20221$15.0M$13.9M93c0
What changed
Every change including routine ones
Identity
Group key
FINCH THERAPEUTICSderivedthe codename stem after legal suffixes and deal words
Spellings
1 across 1 BDCderived
Industry
Drug Discovery & Developmentreportedas one filer wrote it